www.bioprocessonline.com
Open in
urlscan Pro
20.185.12.70
Public Scan
Submitted URL: http://wec.vmpublishinggroup.com/t/470812/21473829/182381/1/
Effective URL: https://www.bioprocessonline.com/docpreview/solving-the-covid-workforce-crisis-0001/166e58ad-daa0-45ee-95f0-c8ba9c2d0a72
Submission Tags: falconsandbox
Submission: On March 12 via api from US — Scanned from DE
Effective URL: https://www.bioprocessonline.com/docpreview/solving-the-covid-workforce-crisis-0001/166e58ad-daa0-45ee-95f0-c8ba9c2d0a72
Submission Tags: falconsandbox
Submission: On March 12 via api from US — Scanned from DE
Form analysis
2 forms found in the DOMGET /search
<form method="get" class="form-inline nav-search pr-0" action="/search">
<input class="form-control-sm" name="keyword" type="search" maxlength="250" placeholder="Search" aria-label="Search">
<button type="submit" class="btn-sm btn-dark">
<i class="fas fa-search fa-sm"></i>
</button>
</form>
<form class="form-horizontal">
<div class="form-group row">
<label class="col-form-label col-form-label-sm text-sm-right col-sm-4 font-weight-bold" for="companyName">Company Name</label>
<div class="col-sm-8">
<input class="form-control-plaintext form-control-sm" id="companyName" name="companyName" readonly="readonly" type="text" value="Cytiva">
</div>
</div>
<div class="form-group row">
<label class="col-form-label col-form-label-sm text-sm-right col-sm-4 font-weight-bold" for="address">Address</label>
<div class="col-sm-8">
<textarea class="form-control-plaintext form-control-sm" id="address" name="address" readonly="readonly" rows="3" style="height: 100%;max-height: 80px;">100 Results Way
Marlborough, MA 08855-1327
US</textarea>
</div>
</div>
<div class="form-group row">
<label class="col-form-label col-form-label-sm text-sm-right col-sm-4 font-weight-bold" for="phone">Phone</label>
<div class="col-sm-8">
<input class="form-control-plaintext form-control-sm" id="phone" name="phone" readonly="readonly" type="text" value="800-526-3593">
</div>
</div>
<div class="form-group row">
<label class="col-form-label col-form-label-sm text-sm-right col-sm-4 font-weight-bold" for="contact">Contact</label>
<div class="col-sm-8">
<input class="form-control-plaintext form-control-sm" id="contact" name="contact" readonly="readonly" type="text">
</div>
</div>
<div class="form-group row">
<label class="col-form-label col-form-label-sm text-sm-right col-sm-4 font-weight-bold" for="links"></label>
<div class="col-sm-8">
<a href="/ecommcenter/cytiva">Company Profile</a><br>
<a href="/lead/new?itemId=466108">Email Us</a>
</div>
</div>
</form>
Text Content
Get more Bioprocess insight with our FREE newsletter sign me up Log In or Subscribe Manufacturing Upstream Downstream Logistics Facility Design Find A Partner Cell Culture Media Fermentation Filtration Fluid Management Purification Market Research Listen & Watch The Business Of Biotech Podcast Bioprocess Online Live Bioprocess With The Bozenhardts PODCAST SOLVING THE COVID-19 WORKFORCE CRISIS Source: Cytiva Obsidian Therapeutics CEO Dr. Paul Wotton didn't let pandemic-induced workforce restrictions impede his biopharma's progress. Instead, his team developed a software system purpose-built for biotechs to manage personnel and equipment per ever-changing guidelines. On this episode of The Business Of Biotech: Summer Executive Sessions, Wotton tells us how the application, dubbed SWIFT, was built, how it's working, and why Obsidian has made it available to more than 30 (and growing) other biotechs, free of charge. CYTIVA * Request Info * Contact Details * Company Profile CONTACT DETAILS × Company Name Address 100 Results Way Marlborough, MA 08855-1327 US Phone Contact Company Profile Email Us MORE FROM CYTIVA * IND FOR TIL THERAPY WITH OBSIDIAN THERAPEUTICS' PAUL WOTTON, PH.D. Obsidian Therapeutics CEO Paul Wotton, Ph.D. takes us behind the scenes to reveal what precipitated the FDA's clearance of its IND application for a novel, engineered tumor-infiltrating... * THE AAV VECTOR CHALLENGE WITH SELECTA'S DR. CARSTEN BRUNN TheBusiness Of Biotech’sCell & Gene Miniseries opens with Dr. Carsten Brunn, President & CEO of Selecta Biosciences. Guest host Erin Harris joins our discussion on Selecta's ImmTOR... * EPISODE 3: THE BIOPHARMA EXIT STRATEGY WITH DR. FRANCOIS NADER On this episode of The Business Of Biotech, we talk with Dr. Francois Nader—a man who's orchestrated several wildly successful biotech exits—about why it's imperative to begin... * GENE THERAPY MANUFACTURING AT-SCALE WITH GEOFF MACKAY Listen in as AVROBIO President & CEO Geoff MacKay tells the Business Of Biotech about the technology his company is using to drive at-scale gene therapy production for lysosomal disorders,... * EPISODE 13: MYELOID CELLS, TRANSPLANTS, & IMMUNO-ONCOLOGY INSPIRATION OSE Immunotherapeutics CEO Alexis Peyroles joins The Business Of Biotech: Summer Executive Sessions to discuss myeloid cells' role in immunology, why a team of transplant specialists is key to... * COMMITMENT TO GMP WITH DR. SHABBIR ANIK * FOUNDATIONS OF BIOPHARMA FINANCE WITH SMITAL SHAH, MBA * GAP ANALYSIS WITH DR. PABLO VALENZUELA & CRISTIÁN HERNÁNDEZ-CUEVAS * DR. RANDY SCHATZMAN ON DODGING DISRUPTION: THE NEW FUNDRAISING NORM * ARROWHEAD PHARMA PRES. & CEO DR. CHRISTOPHER ANZALONE ON TAKING RNA INTERFERENCE BEYOND THE LIVER * CMC CONSIDERATIONS FOR IN-HUMAN STUDIES WITH DRS. EDITH PEREZ AND NATHAN IHLE * EPISODE 2: THE BUSINESS OF BIOTECH: ALLAN SHAW This website uses cookies to ensure you get the best experience on our website. Learn more Got it! PARTNER WITH US * Request More Information * Our Partners SUBSCRIBE * Newsletter * Follow Us on LinkedIn LIFE SCIENCE CONNECT * Biosimilar Development * Cell & Gene * Clinical Leader * Drug Discovery * Laboratory Network * Life Science Leader Magazine * Med Device Online * Outsourced Pharma * Pharmaceutical Online EDITORIAL * Archived Newsletters * Article Reprints * Editorial Submission Guidelines * The Expert Network EVENTS * CMO Leadership Awards * CRO Leadership Awards LEARN MORE * About Us * Contact Us * Work For Us Copyright © 1996-2023 VertMarkets, Inc. All Rights Reserved. Terms of Use. Privacy Statement. Subscriber Request Form. Don't sell my information We'd like to notify you about new and exclusive content from Bioprocess Online AllowNo Thanks